Industry Verticals »

All Categories

Insights »

About TMR »

Antimicrobial Susceptibility Test Market

Antimicrobial Susceptibility Test Market (Product Type - Tests and Kits, Culture Media, Automated Test Systems, Consumables; Method - Broth Dilution Method, Rapid Automated Method, Disk Diffusion Method, Gradient Diffusion Method, Molecular Testing Method; Test Type - Antibacterial, Antifungal, Antiparasitics; Application - Clinical Diagnosis, Drug Discovery and Development; End use - Diagnostic Laboratories and Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global antimicrobial susceptibility test market for the historical period 2017–2018 and forecast period 2019–2027, investments in cutting edge research; rising emphasis on remedies for drug and environmental concerns, increasing incidence of infectious diseases and rising antibiotic resistance are projected to drive the global antimicrobial susceptibility test market during the forecast period.
  • According to the report, the global antimicrobial susceptibility test market was valued at US$ 2,770.9 Mn in 2018 and is anticipated to expand at a CAGR of 4.9% from 2019 to 2027
fa global antimicrobial susceptibility test market

Increasing Microbial Resistance and Surge in Government Funding to drive the Global market: Key Drivers

  • Antimicrobial resistance mechanism are emerging and spreading at a global front, which enables the ways to treat common infectious diseases thus results prolonged illness, disability and at times fatal.  Antimicrobial resistance is a complex situation affecting individuals of all ages and races.
  • According to U.S. Centers for Disease Control and Prevention (CDC) estimated, antibacterial resistance is responsible for over 2 million infections and 23,000 deaths in the U.S. each year and an estimated 25,000 deaths due to antibacterial-resistant infections in Europe. Hence, demand for newer broad spectrum antibacterial drugs is rising. Over 480,000 new cases of multidrug-resistant tuberculosis (MDR-TB) were reported by the WHO in 100 countries in 2013. This increasing microbial resistance is creating a demand for antimicrobial susceptibility tests, contributing to the growth of the global market.
  • Due to the alarming rise of antibacterial resistance and sparse availability of antibacterial drugs which could cater for the treatment of new infections has been noticed by WHO and other government bodies thus WHO has proposed a new Antibiotic Innovation Funding Mechanism where the government would fund grants and innovation induced prizes which would reward upstream innovation, interim trial results and also the end product results
  • Governments in several countries are taking initiatives for the allocation of funds needed to create a sustainable and predictable market

Lack of return on investment to Hamper Market

  • The lack of new, easily identifiable targets, leads to major scientific and technical challenge of new antibacterial drug development increasing the development costs
  • Discovery and development of antibacterial has become scientifically more complex, expensive, and time consuming over the time, as the new generation antimicrobial has raised the bar and the drug screening process tend to rediscover the same lead compounds over and over again. Drug companies too spend more than $100 million for a phase III program of each antimicrobial drug for a particular indication which would constitute only smaller fraction of the total market
  • Antimicrobial drugs are taken for a short period of time to cure the patients unlike other drugs which are used to treat chronic illness and are used for the rest of their lives. This makes antibacterial drugs less lucrative business for drug companies. This lack of return on investment hampers the growth of the global market.

 Global Antimicrobial susceptibility test Market: Competitive Landscape

  • This report profiles major players in the global antimicrobial susceptibility test market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global antimicrobial susceptibility test market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global antimicrobial susceptibility test market are
    • Bio-Rad Laboratories, Inc.
    • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Conda
    • Creative Diagnostics
    • HiMedia Laboratories
    • Alifax Holding S.p.A.
    • Biotron Healthcare

Global Antimicrobial susceptibility test Market: Key Developments

Key players in the global antimicrobial susceptibility test market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global antimicrobial susceptibility test market. A few expansion strategies adopted by players operating in the global antimicrobial susceptibility test market are:

  • In December 2017, Beckman Coulter, Inc. announced FDA clearance for its automated Access AMH immunoassay and paramagnetic particle chemiluminescent immunoassay

 The report on the global antimicrobial susceptibility test market discussed individual strategies, followed by company profiles of manufacturers of antimicrobial susceptibility test. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global antimicrobial susceptibility test market.

Frequently Asked Questions

What is the total market worth of antimicrobial susceptibility test market?

Antimicrobial susceptibility test market to reach US$ 4,224.92 Mn by 2027

What is the anticipated CAGR of the antimicrobial susceptibility test market in the forecast period?

Antimicrobial susceptibility test market is anticipated to expand at a CAGR of 4.9% from 2019 to 2027

What are the key driving factors for the growth of the antimicrobial susceptibility test market?

Antimicrobial susceptibility test market is driven by increasing incidence of infectious diseases and rising antibiotic resistance

Which region is expected to project the highest market share in the global antimicrobial susceptibility test market?

North America dominated the global antimicrobial susceptibility test market, and the trend is anticipated to continue during the forecast period

Who are the key players in the antimicrobial susceptibility test market?

Key players in the global antimicrobial susceptibility test market are Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Antimicrobial Susceptibility Test Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Market Opportunity Map, by Product Type

    5.2. Porter’s Five Force Analysis

    5.3. Prevalence of Major Infectious Diseases

    5.4. Technological Advancement

    5.5. Advantages and Disadvantages of Methods used for Antimicrobial Susceptibility Testing

6. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Product Type, 2017–2027

        6.2.1.  Kits, Reagents & Consumables

        6.2.2. Culture Media

        6.2.3. Automated Test System

    6.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Product Type

7. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Method

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Method, 2017–2027

        7.2.1. Broth Dilution Method 

        7.2.2. Rapid Automated Method 

        7.2.3. Disk Diffusion Method

        7.2.4. Gradient Diffusion Method

        7.2.5. Molecular Testing Method

    7.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Method 

8. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Test Type

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Test Type, 2017–2027

        8.2.1. Antibacterial

        8.2.2. Antifungal

        8.2.3. Antiparasitic

        8.2.4. Others

    8.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Test Type 

9. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Application

    9.1. Introduction & Definition

        9.1.1. Key Findings / Developments

    9.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Application, 2017–2027

        9.2.1. Clinical Diagnosis

        9.2.2. Drug Discovery and Development

        9.2.3. Others

    9.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by Application 

10. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by End-user

    10.1. Introduction & Definition

        10.1.1. Key Findings / Developments

    10.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by End-user, 2017–2027

        10.2.1. Diagnostic Laboratories and Hospitals

        10.2.2. Pharmaceutical and Biotechnology Companies

        10.2.3. Research and Academic Institutes

        10.2.4. Contract Research Organizations

    10.3. Global Antimicrobial Susceptibility Test Market Attractiveness, by End-user

11. Global Antimicrobial Susceptibility Test Market Analysis and Forecast, by Region

    11.1. Key Findings

    11.2. Global Antimicrobial Susceptibility Test Market Value Forecast, by Region

        11.2.1. North America 

        11.2.2. Europe 

        11.2.3. Asia Pacific 

        11.2.4. Latin America 

        11.2.5. Middle East & Africa 

    11.3. North America Antimicrobial Susceptibility Test Market Attractiveness, by Region

12. North America Antimicrobial Susceptibility Test Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        12.2.1. Kits, Reagents & Consumables

        12.2.2. Culture Media

        12.2.3. Automated Test System

    12.3. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        12.3.1. Broth Dilution Method 

        12.3.2. Rapid Automated Method 

        12.3.3. Disk Diffusion Method

        12.3.4. Gradient Diffusion Method

        12.3.5. Molecular Testing Method

    12.4. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        12.4.1. Antibacterial

        12.4.2. Antifungal

        12.4.3. Antiparasitic

        12.4.4. Others

    12.5. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.5.1. Clinical Diagnosis

        12.5.2. Drug Discovery and Development

        12.5.3. Others

    12.6. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        12.6.1. Diagnostic Laboratories and Hospitals

        12.6.2. Pharmaceutical and Biotechnology Companies

        12.6.3. Research and Academic Institutes

        12.6.4. Contract Research Organizations

    12.7. North America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        12.7.1. U.S.

        12.7.2. Canada

    12.8. North America Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        12.8.1. By Product Type

        12.8.2. By Method

        12.8.3. By Test Type

        12.8.4. By Application 

        12.8.5. By End-user

        12.8.6. By Country

13. Europe Antimicrobial Susceptibility Test Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        13.2.1. Kits, Reagents & Consumables

        13.2.2. Culture Media

        13.2.3. Automated Test System

    13.3. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        13.3.1. Broth Dilution Method 

        13.3.2. Rapid Automated Method 

        13.3.3. Disk Diffusion Method

        13.3.4. Gradient Diffusion Method

        13.3.5. Molecular Testing Method

    13.4. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        13.4.1. Antibacterial

        13.4.2. Antifungal

        13.4.3. Antiparasitic

        13.4.4. Others

    13.5. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        13.5.1. Clinical Diagnosis

        13.5.2. Drug Discovery and Development

        13.5.3. Others

    13.6. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        13.6.1. Diagnostic Laboratories and Hospitals

        13.6.2. Pharmaceutical and Biotechnology Companies

        13.6.3. Research and Academic Institutes

        13.6.4. Contract Research Organizations

    13.7. Europe Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        13.7.1. U.K.

        13.7.2. Germany

        13.7.3. France

        13.7.4. Italy 

        13.7.5. Spain

        13.7.6. Rest of Europe

    13.8. Europe Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        13.8.1. By Product Type

        13.8.2. By Method

        13.8.3. By Test Type

        13.8.4. By Application 

        13.8.5. By End-user

        13.8.6. By Country

14. Asia Pacific Antimicrobial Susceptibility Test Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        14.2.1. Kits, Reagents & Consumables

        14.2.2. Culture Media

        14.2.3. Automated Test System

    14.3. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        14.3.1. Broth Dilution Method 

        14.3.2. Rapid Automated Method 

        14.3.3. Disk Diffusion Method

        14.3.4. Gradient Diffusion Method

        14.3.5. Molecular Testing Method

    14.4. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        14.4.1. Antibacterial

        14.4.2. Antifungal

        14.4.3. Antiparasitic

        14.4.4. Others

    14.5. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        14.5.1. Clinical Diagnosis

        14.5.2. Drug Discovery and Development

        14.5.3. Others

    14.6. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        14.6.1. Diagnostic Laboratories and Hospitals

        14.6.2. Pharmaceutical and Biotechnology Companies

        14.6.3. Research and Academic Institutes

        14.6.4. Contract Research Organizations

    14.7. Asia Pacific Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        14.7.1. China

        14.7.2. Japan

        14.7.3. Australia & New Zealand

        14.7.4. India

        14.7.5. Rest of Asia Pacific

    14.8. Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        14.8.1. By Product Type

        14.8.2. By Method

        14.8.3. By Test Type

        14.8.4. By Application 

        14.8.5. By End-user

        14.8.6. By Country

15. Latin America Antimicrobial Susceptibility Test Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        15.2.1. Kits, Reagents & Consumables

        15.2.2. Culture Media

        15.2.3. Automated Test System

    15.3. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        15.3.1. Broth Dilution Method 

        15.3.2. Rapid Automated Method 

        15.3.3. Disk Diffusion Method

        15.3.4. Gradient Diffusion Method

        15.3.5. Molecular Testing Method

    15.4. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        15.4.1. Antibacterial

        15.4.2. Antifungal

        15.4.3. Antiparasitic

        15.4.4. Others

    15.5. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        15.5.1. Clinical Diagnosis

        15.5.2. Drug Discovery and Development

        15.5.3. Others

    15.6. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        15.6.1. Diagnostic Laboratories and Hospitals

        15.6.2. Pharmaceutical and Biotechnology Companies

        15.6.3. Research and Academic Institutes

        15.6.4. Contract Research Organizations

    15.7. Latin America Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        15.7.1. Brazil

        15.7.2. Mexico

        15.7.3. Rest of Latin America

    15.8. Latin America Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        15.8.1. By Product Type

        15.8.2. By Method

        15.8.3. By Test Type

        15.8.4. By Application 

        15.8.5. By End-user

        15.8.6. By Country

16. Middle East & Africa Antimicrobial Susceptibility Test Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Key Findings

    16.2. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        16.2.1. Kits, Reagents & Consumables

        16.2.2. Culture Media

        16.2.3. Automated Test System

    16.3. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Method, 2017–2027

        16.3.1. Broth Dilution Method 

        16.3.2. Rapid Automated Method 

        16.3.3. Disk Diffusion Method

        16.3.4. Gradient Diffusion Method

        16.3.5. Molecular Testing Method

    16.4. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

        16.4.1. Antibacterial

        16.4.2. Antifungal

        16.4.3. Antiparasitic

        16.4.4. Others

    16.5. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Application, 2017–2027

        16.5.1. Clinical Diagnosis

        16.5.2. Drug Discovery and Development

        16.5.3. Others

    16.6. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        16.6.1. Diagnostic Laboratories and Hospitals

        16.6.2. Pharmaceutical and Biotechnology Companies

        16.6.3. Research and Academic Institutes

        16.6.4. Contract Research Organizations

    16.7. Middle East & Africa Antimicrobial Susceptibility Test Market Value (US$ Mn) Forecast, by Country, 2017–2027

        16.7.1. GCC Countries 

        16.7.2. South Africa

        16.7.3. Israel

        16.7.4. Rest of Middle East & Africa

    16.8. Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness Analysis 

        16.8.1. By Product Type

        16.8.2. By Method

        16.8.3. By Test Type

        16.8.4. By Application 

        16.8.5. By End-user

        16.8.6. By Country

17. Competition Landscape

    17.1. Market Player - Competition Matrix (by Tier and Size of companies)

    17.2. Market Share / Position Analysis, by Company, 2018

    17.3. Company Profiles

        17.3.1. Bio-Rad Laboratories, Inc.

            17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.1.2. Financial Overview

            17.3.1.3. Product Portfolio

            17.3.1.4. SWOT Analysis

            17.3.1.5. Strategic Overview

        17.3.2. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

            17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.2.2. Financial Overview

            17.3.2.3. Product Portfolio

            17.3.2.4. SWOT Analysis

            17.3.2.5. Strategic Overview

        17.3.3. Thermo Fisher Scientific, Inc.

            17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.3.2. Financial Overview

            17.3.3.3. Product Portfolio

            17.3.3.4. SWOT Analysis

            17.3.3.5. Strategic Overview

        17.3.4. Becton, Dickinson and Company

            17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.4.2. Financial Overview

            17.3.4.3. Product Portfolio

            17.3.4.4. SWOT Analysis

            17.3.4.5. Strategic Overview

        17.3.5. Conda

            17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.5.2. Financial Overview

            17.3.5.3. Product Portfolio

            17.3.5.4. SWOT Analysis

            17.3.5.5. Strategic Overview

        17.3.6. Creative Diagnostics

            17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.6.2. Financial Overview

            17.3.6.3. Product Portfolio

            17.3.6.4. SWOT Analysis

            17.3.6.5. Strategic Overview

        17.3.7. HiMedia Laboratories

            17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.7.2. Financial Overview

            17.3.7.3. Product Portfolio

            17.3.7.4. SWOT Analysis

            17.3.7.5. Strategic Overview         

        17.3.8. Alifax Holding S.p.A.

            17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.8.2. Financial Overview

            17.3.8.3. Product Portfolio

            17.3.8.4. SWOT Analysis

            17.3.8.5. Strategic Overview

        17.3.9. Danaher Corporation (Cepheid)

            17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.9.2. Financial Overview

            17.3.9.3. Product Portfolio

            17.3.9.4. SWOT Analysis

            17.3.9.5. Strategic Overview

        17.3.10. Biotron Healthcare 

            17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            17.3.10.2. Financial Overview

            17.3.10.3. Product Portfolio

            17.3.10.4. SWOT Analysis

            17.3.10.5. Strategic Overview

List of Tables

Table 01: Global Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Product Type , 2017–2027

Table 02: Global Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Method , 2017–2027

Table 03: Global Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Test Type , 2017–2027

Table 04: Global Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Application, 2017–2027

Table 05: Global Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by End Users, 2017–2027

Table 06: Global Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 07: North America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Product Type , 2017–2027

Table 08: North America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Method , 2017–2027

Table 09: North America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Test Type , 2017–2027

Table 10: North America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Application , 2017–2027

Table 11: North America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by End Users , 2017–2027

Table 12: North America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Country , 2017–2027

Table 13: Europe Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Product Type , 2017–2027

Table 14: Europe Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Method , 2017–2027

Table 15: Europe Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Test Type , 2017–2027

Table 16: Europe Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Application , 2017–2027

Table 17: Europe Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by End Users , 2017–2027

Table 18: Europe Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

Table 19: Asia Pacific Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Product Type , 2017–2027

Table 20: Asia Pacific Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Method , 2017–2027

Table 21: Asia Pacific Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Test Type , 2017–2027

Table 22: Asia Pacific Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Application , 2017–2027

Table 23: Asia Pacific Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by End Users , 2017–2027

Table 24: Asia Pacific Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

Table 25: Latin America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Product Type , 2017–2027

Table 26: Latin America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Method , 2017–2027

Table 27: Latin America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Test Type , 2017–2027

Table 28: Latin America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Application , 2017–2027

Table 29: Latin America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by End Users , 2017–2027

Table 30: Latin America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

Table 31: Middle East & Africa Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Product Type , 2017–2027

Table 32: Middle East & Africa Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Method , 2017–2027

Table 33: Middle East & Africa Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Test Type , 2017–2027

Table 34: Middle East & Africa Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Application , 2017–2027

Table 35: Middle East & Africa Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by End Users , 2017–2027

Table 36: Middle East & Africa Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

List of Figure

Figure 01: Global Antimicrobial Susceptibility Test Market Snapshot

Figure 02: Global Key Trends Analysis, 2018

Figure 03: Market Share Analysis by Region, 2018

Figure 04: Market Opportunity Map, by Product Type, 2019-2027

Figure 05: Market Opportunity Map, by Method, 2019-2027

Figure 06: Market Opportunity Map, by Test Type, 2019-2027

Figure 07: Market Opportunity Map, by Application, 2019-2027

Figure 08: Market Opportunity Map, by End Users, 2019-2027

Figure 09: Market Opportunity Map, by Region, 2019-2027

Figure 10: Global Antimicrobial Susceptibility Test Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 11: Global Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 12: Global Test & Kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 13: Global Culture Media Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 14: Global Automated Test Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 15: Global Consumables Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 16: Global Antimicrobial Susceptibility Test Market Value Share Analysis, by Method , 2018 and 2027

Figure 17: Global Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Method , 2019–2027

Figure 18: Global Broth Dilution Method Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 19: Global Rapid Automated Method Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 20: Global Disk Diffusion Method Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 21: Global Gradient Diffusion Method Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 22: Global Molecular Testing Method Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 23: Global Antimicrobial Susceptibility Test Market Value Share Analysis, by Test Type , 2018 and 2027

Figure 24: Global Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Test Type , 2019–2027

Figure 25: Global Antibacteria Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 26: Global Antifungal Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 27: Global Antiparasitic Method Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 28: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 29: Global Antimicrobial Susceptibility Test Market Value Share Analysis, by Application , 2018 and 2027

Figure 30: Global Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Application , 2019–2027

Figure 31: Global Clinical Diagnosis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 32: Global Drug Discovery and Development Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 33: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 34: Global Antimicrobial Susceptibility Test Market Value Share Analysis, by End Users , 2018 and 2027

Figure 35: Global Antimicrobial Susceptibility Test Market Attractiveness Analysis, by End Users , 2019–2027

Figure 36: Global Diagnostic Laboratories and Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 37: Global Pharmaceutical and Biotechnology Companies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 38: Global Research and Academic Institutes Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 39: Global Contract Research Organizations Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2027

Figure 40: Global Antimicrobial Susceptibility Test Market Value Share Analysis, by Region, 2018 and 2027

Figure 41: Global Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Region, 2019–2027

Figure 42: North America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, 2017–2027

Figure 43: North America Antimicrobial Susceptibility Test Market Y-o-Y Growth Projections, 2018–2027

Figure 44: North America Antimicrobial Susceptibility Test Market Value Share Analysis, by Product Type , 2018 and 2027

Figure 45: North America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 46: North America Antimicrobial Susceptibility Test Market Value Share Analysis, by Method , 2018 and 2027

Figure 47: North America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Method , 2019–2027

Figure 48: North America Antimicrobial Susceptibility Test Market Value Share Analysis, by Test Type , 2018 and 2027

Figure 49: North America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Test Type , 2019–2027

Figure 50: North America Antimicrobial Susceptibility Test Market Value Share Analysis, by Application , 2018 and 2027

Figure 51: North America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Application , 2019–2027

Figure 52: North America Antimicrobial Susceptibility Test Market Value Share Analysis, by End USers , 2018 and 2027

Figure 53: North America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by End Users , 2019–2027

Figure 54: North America Antimicrobial Susceptibility Test Market Value Share Analysis, by Country , 2018 and 2027

Figure 55: North America Antimicrobial Susceptibility Test Market Attractiveness, by Country, 2019-2027

Figure 56: Europe Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, 2017–2027

Figure 57: Europe Antimicrobial Susceptibility Test Market Y-o-Y Growth Projections, 2018–2027

Figure 58: Europe Antimicrobial Susceptibility Test Market Value Share Analysis, by Product Type , 2018 and 2027

Figure 59: Europe Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 60: Europe Antimicrobial Susceptibility Test Market Value Share Analysis, by Method , 2018 and 2027

Figure 61: Europe Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Method , 2019–2027

Figure 62: Europe Antimicrobial Susceptibility Test Market Value Share Analysis, by Test Type , 2018 and 2027

Figure 63: Europe Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Test Type , 2019–2027

Figure 64: Europe Antimicrobial Susceptibility Test Market Value Share Analysis, by Application , 2018 and 2027

Figure 65: Europe Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Application , 2019–2027

Figure 66: Europe Antimicrobial Susceptibility Test Market Value Share Analysis, by End USers , 2018 and 2027

Figure 67: Europe Antimicrobial Susceptibility Test Market Attractiveness Analysis, by End Users , 2019–2027

Figure 69: Europe Antimicrobial Susceptibility Test Market Value Share Analysis, by Country/Sub-region , 2018 and 2027

Figure 70: Europe Antimicrobial Susceptibility Test Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 71: Asia Pacific Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, 2017–2027

Figure 72: Asia Pacific Antimicrobial Susceptibility Test Market Y-o-Y Growth Projections, 2018–2027

Figure 73: Asia Pacific Antimicrobial Susceptibility Test Market Value Share Analysis, by Product Type , 2018 and 2027

Figure 74: Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 75: Asia Pacific Antimicrobial Susceptibility Test Market Value Share Analysis, by Method , 2018 and 2027

Figure 76: Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Method , 2019–2027

Figure 77: Asia Pacific Antimicrobial Susceptibility Test Market Value Share Analysis, by Test Type , 2018 and 2027

Figure 78: Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Test Type , 2019–2027

Figure 79: Asia Pacific Antimicrobial Susceptibility Test Market Value Share Analysis, by Application , 2018 and 2027

Figure 80: Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Application , 2019–2027

Figure 81: Asia Pacific Antimicrobial Susceptibility Test Market Value Share Analysis, by End USers , 2018 and 2027

Figure 82: Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness Analysis, by End Users , 2019–2027

Figure 83: Asia Pacific Antimicrobial Susceptibility Test Market Value Share Analysis, by Country/Sub-region , 2018 and 2027

Figure 84: Asia Pacific Antimicrobial Susceptibility Test Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 85: Latin America Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, 2017–2027

Figure 86: Latin America Antimicrobial Susceptibility Test Market Y-o-Y Growth Projections, 2018–2027

Figure 87: Latin America Antimicrobial Susceptibility Test Market Value Share Analysis, by Product Type , 2018 and 2027

Figure 88: Latin America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 89: Latin America Antimicrobial Susceptibility Test Market Value Share Analysis, by Method , 2018 and 2027

Figure 90: Latin America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Method , 2019–2027

Figure 91: Latin America Antimicrobial Susceptibility Test Market Value Share Analysis, by Test Type , 2018 and 2027

Figure 92: Latin America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Test Type , 2019–2027

Figure 93: Latin America Antimicrobial Susceptibility Test Market Value Share Analysis, by Application , 2018 and 2027

Figure 94: Latin America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Application , 2019–2027

Figure 95: Latin America Antimicrobial Susceptibility Test Market Value Share Analysis, by End USers , 2018 and 2027

Figure 96: Latin America Antimicrobial Susceptibility Test Market Attractiveness Analysis, by End Users , 2019–2027

Figure 97: Latin America Antimicrobial Susceptibility Test Market Value Share Analysis, by Country/Sub-region , 2018 and 2027

Figure 98: Latin America Antimicrobial Susceptibility Test Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 99: Middle East & Africa Antimicrobial Susceptibility Test Market Size (US$ Mn) Forecast, 2017–2027

Figure 100: Middle East & Africa Antimicrobial Susceptibility Test Market Y-o-Y Growth Projections, 2018–2027

Figure 101: Middle East & Africa Antimicrobial Susceptibility Test Market Value Share Analysis, by Product Type , 2018 and 2027

Figure 102: Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 103: Middle East & Africa Antimicrobial Susceptibility Test Market Value Share Analysis, by Method , 2018 and 2027

Figure 104: Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Method , 2019–2027

Figure 105: Middle East & Africa Antimicrobial Susceptibility Test Market Value Share Analysis, by Test Type , 2018 and 2027

Figure 106: Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Test Type , 2019–2027

Figure 107: Middle East & Africa Antimicrobial Susceptibility Test Market Value Share Analysis, by Application , 2018 and 2027

Figure 108: Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness Analysis, by Application , 2019–2027

Figure 109: Middle East & Africa Antimicrobial Susceptibility Test Market Value Share Analysis, by End USers , 2018 and 2027

Figure 110: Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness Analysis, by End Users , 2019–2027

Figure 111: Middle East & Africa Antimicrobial Susceptibility Test Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 112: Middle East & Africa Antimicrobial Susceptibility Test Market Attractiveness, by Country/Sub-region, 2019-2027

Figure 113: Global Antimicrobial Susceptibility Test Market Share Analysis, by Company (2018)

Copyright © Transparency Market Research, Inc. All Rights reserved

Antimicrobial Susceptibility Test Market

Schedule a Call